As children return to school and families resume busy fall schedules, it’s important to stay safe and healthy by getting ...

EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...

This condition has been associated with reactions found in individuals who received the Pfizer BioNTech COVID vaccine, particularly among older women within the first week of vaccination. This curious ...

Updated COVID-19 vaccines are now widely available at many pharmacies, but for New Mexicans who lack insurance, the wait will be longer and supplies less certain. The New Mexico Department of Health ...

Stay updated on the latest analyst actions and market trends with this financial article covering upgrades and downgrades for ...

The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...

The BioNTech SE ADR BNTX shed 0.20% to $112.28 Friday, on what proved to be an all-around mixed trading session for the stock ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...